[
  {
    "vignette_index": 955,
    "input": "Traumatic subconjunctival hemorrhage END",
    "output": "THINKING: The patient has a traumatic subconjunctival hemorrhage, confirmed with targeted history and exam, and has underlying von Willebrand disease, which predisposes to bleeding. The severity appears moderate given symptoms of redness, swelling, tearing, and recent trauma, but no mention of vision loss or globe rupture, thus urgent care is indicated but not immediate life-threatening emergency. Differential considerations include more severe ocular trauma or bleeding disorders exacerbating the hemorrhage.  For treatment, conservative management emphasizing reassurance and monitoring is appropriate, as subconjunctival hemorrhages generally resolve spontaneously within 1-3 weeks. In the context of von Willebrand disease, caution is needed with any invasive procedures or trauma management; coordination with hematology for bleeding status is vital.  Pharmacological intervention typically is minimal, but ensuring optimized hemostatic control in the context of von Willebrand disease is crucial. Non-pharmacological measures include eye protection and patient education. Follow-up within 1-2 weeks allows assessment of resolution and ensures no progression or complication.  Communication should be clear and reassuring, given the patient's baseline, emphasizing the benign nature of subconjunctival hemorrhage but the importance of bleeding disorder management. Coordination with hematology is essential for ongoing management of vWD, especially if intervention is needed.\nANSWER: Based on the diagnosis of traumatic subconjunctival hemorrhage in a patient with von Willebrand disease, I recommend a comprehensive treatment approach that combines conservative ocular management and bleeding control strategies. The plan emphasizes reassurance, careful monitoring, and coordination with hematology to optimize bleeding management, with attention to patient education and follow-up.  Initial management includes advising the patient to avoid rubbing or trauma to the eye, use of artificial tears for comfort, and eye protection during activities. No specific ocular medications are typically necessary unless secondary complications arise. Coordination with the hematology team to ensure the patient's von Willebrand factor levels are adequately managed is essential, especially if interventions or activities pose bleeding risks.  Follow-up should occur within 1 to 2 weeks to assess resolution of the hemorrhage and ensure no new symptoms develop. The patient should be instructed to seek immediate care if they experience vision changes, increasing pain, worsening swelling, or signs of ocular compartment syndrome.  Communication should be straightforward, emphasizing that subconjunctival hemorrhages usually resolve spontaneously, but that the underlying bleeding disorder requires ongoing management. Reinforce importance of protecting the eye and adhering to hematologic management plans.  The plan aims to promote resolution, prevent recurrent bleeding, and coordinate long-term care for the patient\u2019s von Willebrand disease, minimizing risks of bleeding complications related to trauma.  IMPLEMENTATION GUIDANCE: - Immediate actions (today): Educate the patient about the benign nature of the hemorrhage, advise eye protection, and confirm hematology follow-up for vWD management. - Short-term goals (1-4 weeks): Monitor for spontaneous resolution of hemorrhage, ensure no secondary complications, and maintain hematologic stability. - Long-term objectives (3-6 months): Achieve optimal control of von Willebrand disease, prevent recurrent hemorrhages, and educate on injury prevention. - Patient handout summary: Reassure that subconjunctival hemorrhages generally resolve on their own, avoid rubbing the eye, protect the eye from injury, follow up with hematology, and seek urgent care if vision changes or pain worsen.",
    "gold_diagnosis": "Von Willebrand disease"
  }
]